Literature DB >> 19607965

Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.

Patrizia Campolongo1, Viviana Trezza, Maura Palmery, Luigia Trabace, Vincenzo Cuomo.   

Abstract

Cannabis sativa preparations are among the illicit drugs most commonly used by pregnant women in Western countries. Although they are often considered relatively harmless, increasing evidence suggests that developmental exposure to cannabinoids induces subtle neurofunctional alterations in the offspring. In the present review, we summarize human and animal evidence examining the behavioral and neurobiological effects of exposure to cannabinoids during pregnancy and lactation. These studies show that the endocannabinoid system plays a crucial role in the ontogeny of the central nervous system and its activation, during brain development, can induce subtle and long-lasting neurofunctional alterations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19607965     DOI: 10.1016/S0074-7742(09)85009-5

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  23 in total

Review 1.  ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015.

Authors:  Sarah Reece-Stremtan; Kathleen A Marinelli
Journal:  Breastfeed Med       Date:  2015-04       Impact factor: 1.817

2.  Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study.

Authors:  Jean Y Ko; Van T Tong; Jennifer M Bombard; Donald K Hayes; John Davy; Katherine A Perham-Hester
Journal:  Drug Alcohol Depend       Date:  2018-03-29       Impact factor: 4.492

Review 3.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

Review 4.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

5.  Use of paracetamol, ibuprofen or aspirin in pregnancy and risk of cerebral palsy in the child.

Authors:  Tanja Gram Petersen; Zeyan Liew; Anne-Marie Nybo Andersen; Guro L Andersen; Per Kragh Andersen; Torben Martinussen; Jørn Olsen; Cristina Rebordosa; Mette Christophersen Tollånes; Peter Uldall; Allen J Wilcox; Katrine Strandberg-Larsen
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

6.  Drugs of Abuse in Human Milk Purchased via the Internet.

Authors:  Sarah A Keim; Kelly McNamara; Jesse J Kwiek; Sheela R Geraghty
Journal:  Breastfeed Med       Date:  2015-10-13       Impact factor: 1.817

Review 7.  It's not your mother's marijuana: effects on maternal-fetal health and the developing child.

Authors:  Tamara D Warner; Dikea Roussos-Ross; Marylou Behnke
Journal:  Clin Perinatol       Date:  2014-09-27       Impact factor: 3.430

8.  Tonic and transient endocannabinoid regulation of AMPAergic miniature postsynaptic currents and homeostatic plasticity in embryonic motor networks.

Authors:  Carlos Gonzalez-Islas; Miguel Angel Garcia-Bereguiain; Peter Wenner
Journal:  J Neurosci       Date:  2012-09-26       Impact factor: 6.167

Review 9.  The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients Through a Written Document.

Authors:  Barth Wilsey; J Hampton Atkinson; Thomas D Marcotte; Igor Grant
Journal:  Clin J Pain       Date:  2015-12       Impact factor: 3.442

Review 10.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.